Cubist Systematic Strategies’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-381
Closed -$6.02K 3479
2023
Q2
$6.02K Buy
+381
New +$8.71K ﹤0.01% 3294
2023
Q1
Sell
-471
Closed -$16.8K 4015
2022
Q4
$16.8K Sell
471
-4,229
-90% -$167K ﹤0.01% 4010
2022
Q3
$183K Buy
4,700
+1,600
+52% +$76K ﹤0.01% 3814
2022
Q2
$149K Sell
3,100
-336
-10% -$19.7K ﹤0.01% 3821
2022
Q1
$317K Buy
+3,436
New +$467K ﹤0.01% 2812
2021
Q4
Sell
-1,939
Closed -$671K 3500
2021
Q3
$671K Buy
1,939
+699
+56% +$237K 0.01% 1828
2021
Q2
$466K Buy
1,240
+870
+235% +$261K 0.01% 2065
2021
Q1
$115K Sell
370
-75
-17% -$26.3K ﹤0.01% 2614
2020
Q4
$111K Buy
445
+262
+143% +$64.2K ﹤0.01% 2391
2020
Q3
$34K Sell
183
-1,665
-90% -$331K ﹤0.01% 2389
2020
Q2
$462K Buy
1,848
+1,221
+195% +$267K 0.01% 1627
2020
Q1
$113K Buy
+627
New +$164K ﹤0.01% 1881
2019
Q3
Sell
-368
Closed -$146K 2265
2019
Q2
$146K Buy
+368
New +$148K ﹤0.01% 2162

Other funds holding DTIL

Cubist Systematic Strategies's DTIL Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Precision BioSciences (DTIL) in Q3 2023, closing a stake of 381 shares — an estimated $6.02K sold.

Cubist Systematic Strategies first reported a position in DTIL in Q2 2019 and held it in 13 quarters. The position peaked at $671K in Q3 2021. 76 funds tracked by Wall St. Rank hold DTIL as of Q3 2023.

  • Cubist Systematic Strategies reported no remaining Precision BioSciences position as of Q3 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 381 Precision BioSciences shares in Q3 2023, an estimated $6.02K.
  • Cubist Systematic Strategies first reported a position in Precision BioSciences in Q2 2019 and held it in 13 quarters.
  • Cubist Systematic Strategies's Precision BioSciences position peaked at $671K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.